James Baggs

8.9k total citations · 4 hit papers
135 papers, 5.9k citations indexed

About

James Baggs is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, James Baggs has authored 135 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Infectious Diseases, 55 papers in Epidemiology and 28 papers in Applied Microbiology and Biotechnology. Recurrent topics in James Baggs's work include Antibiotic Use and Resistance (28 papers), Vaccine Coverage and Hesitancy (27 papers) and SARS-CoV-2 and COVID-19 Research (18 papers). James Baggs is often cited by papers focused on Antibiotic Use and Resistance (28 papers), Vaccine Coverage and Hesitancy (27 papers) and SARS-CoV-2 and COVID-19 Research (18 papers). James Baggs collaborates with scholars based in United States, Uganda and Australia. James Baggs's co-authors include John A. Jernigan, Eric Weintraub, Kelly M Hatfield, Edward A. Belongia, Nicola P. Klein, L. Clifford McDonald, Allison L. Naleway, Julianne Gee, Sujan Reddy and Lisa A. Jackson and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

James Baggs

124 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States

2019 499 citations Athena P. Kourtis, Kelly M Hatfield et al. MMWR Morbidity and Mortality Weekly Report profile →
Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017

2020 384 citations John A. Jernigan, Kelly M Hatfield et al. profile →
Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children

2021 233 citations Lyudmyla Kompaniyets, Jean Y. Ko et al. JAMA Network Open profile →
Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021

2021 203 citations Lyudmyla Kompaniyets, Audrey F. Pennington et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Baggs United States	40	2.8k	2.0k	944	657	496	135	5.9k
Susan Hopkins United Kingdom	39	3.3k 1.2×	1.8k 0.9×	706 0.7×	549 0.8×	1.4k 2.8×	198	7.0k
Anthony E. Fiore United States	44	2.5k 0.9×	7.5k 3.7×	1.3k 1.4×	447 0.7×	255 0.5×	91	10.9k
Neil French United Kingdom	44	3.0k 1.1×	3.5k 1.7×	291 0.3×	307 0.5×	165 0.3×	194	7.2k
Benjamin Schwartz United States	68	4.9k 1.8×	5.6k 2.8×	1.3k 1.4×	689 1.0×	1.1k 2.1×	187	13.5k
David Chien Lye Singapore	54	5.5k 2.0×	1.7k 0.8×	398 0.4×	337 0.5×	698 1.4×	314	9.5k
Andrew T. Pavia United States	55	2.9k 1.0×	6.2k 3.1×	245 0.3×	445 0.7×	782 1.6×	208	10.0k
Daniel B. Jernigan United States	49	4.7k 1.7×	5.8k 2.9×	1.1k 1.2×	610 0.9×	404 0.8×	109	11.0k
Ping‐Ing Lee Taiwan	43	2.8k 1.0×	3.0k 1.5×	283 0.3×	859 1.3×	119 0.2×	238	7.0k
Pierre Tattevin France	45	4.0k 1.4×	3.9k 1.9×	159 0.2×	1.2k 1.8×	314 0.6×	331	8.2k
Gary Garber Canada	41	2.1k 0.8×	2.7k 1.3×	385 0.4×	273 0.4×	591 1.2×	205	6.7k

Countries citing papers authored by James Baggs

Since Specialization

Citations

This map shows the geographic impact of James Baggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Baggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Baggs more than expected).

Fields of papers citing papers by James Baggs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Baggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Baggs. The network helps show where James Baggs may publish in the future.

Co-authorship network of co-authors of James Baggs

This figure shows the co-authorship network connecting the top 25 collaborators of James Baggs. A scholar is included among the top collaborators of James Baggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Baggs. James Baggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Biggs, Holly M., Rongxia Li, Kelly A. Jackson, et al.. (2025). Trends in Incidence and Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia, Six Emerging Infections Program Surveillance Sites, 2005–2022. Open Forum Infectious Diseases. 12(6). ofaf282–ofaf282. 1 indexed citations

Currie, Dustin W., Joseph D. Lutgring, Sophia V. Kazakova, et al.. (2025). Comparison of Medicare claims-based Clostridioides difficile infection epidemiologic case classification algorithms to medical record review by the Emerging Infections Program using a linked cohort, 2016–2021. Infection Control and Hospital Epidemiology. 46(5). 488–496.

Wolford, Hannah, Natalie McCarthy, James Baggs, et al.. (2025). Antimicrobial-Resistant Infections in Hospitalized Patients. JAMA Network Open. 8(3). e2462059–e2462059. 6 indexed citations

Scott, R. Douglas, Steven D. Culler, James Baggs, et al.. (2024). Measuring the Direct Medical Costs of Hospital-Onset Infections Using an Analogy Costing Framework. PharmacoEconomics. 42(10). 1127–1144.

McCarthy, Natalie, James Baggs, Hannah Wolford, et al.. (2024). Length of antibiotic therapy among adults hospitalized with uncomplicated community-acquired pneumonia, 2013–2020. Infection Control and Hospital Epidemiology. 45(6). 726–732. 2 indexed citations

Woo, Emily Jane, Julianne Gee, Paige Marquez, et al.. (2023). Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022. Vaccine. 41(30). 4422–4430. 8 indexed citations

Wolford, Hannah, James Baggs, Sujan Reddy, et al.. (2023). Antibiotic Use Among Hospitalized Patients With COVID-19 in the United States, March 2020–June 2022. Open Forum Infectious Diseases. 10(11). ofad503–ofad503. 6 indexed citations

Hatfield, Kelly M, James Baggs, Sarah Warner, et al.. (2023). Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022. JAMA Network Open. 6(8). e2329441–e2329441. 10 indexed citations

Kazakova, Sophia V., James Baggs, Hussain Yusuf, et al.. (2022). Declines in the utilization of hospital‐based care during COVID‐19 pandemic. Journal of Hospital Medicine. 17(12). 984–989. 16 indexed citations

10.

Baggs, James, Sophia V. Kazakova, Alice Guh, et al.. (2022). Trends in facility-level rates of Clostridioides difficile infections in US hospitals, 2019–2020. Infection Control and Hospital Epidemiology. 44(2). 238–245. 5 indexed citations

11.

Baggs, James, Hannah Wolford, Melinda M. Neuhauser, et al.. (2021). Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic. Open Forum Infectious Diseases. 8(6). 44 indexed citations

12.

Chapin-Bardales, Johanna, Tanya R. Myers, Julianne Gee, et al.. (2021). Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system. Vaccine. 39(48). 7066–7073. 10 indexed citations

13.

Kourtis, Athena P., Kelly M Hatfield, James Baggs, et al.. (2019). Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States. MMWR Morbidity and Mortality Weekly Report. 68(9). 214–219. 499 indexed citations breakdown →

14.

Guh, Alice, Yi Mu, James Baggs, et al.. (2018). Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015. American Journal of Infection Control. 46(7). 840–842. 17 indexed citations

15.

Baggs, James, Kimberly Yousey‐Hindes, Elizabeth Dodds Ashley, et al.. (2015). Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. Vaccine. 33(46). 6241–6249. 10 indexed citations

16.

Irving, Stephanie A., Burney A. Kieke, James G. Donahue, et al.. (2013). Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion. Obstetrics and Gynecology. 121(1). 159–165. 65 indexed citations

17.

Belongia, Edward A., Stephanie A. Irving, Irene M. Shui, et al.. (2009). Real-Time Surveillance to Assess Risk of Intussusception and Other Adverse Events After Pentavalent, Bovine-Derived Rotavirus Vaccine. The Pediatric Infectious Disease Journal. 29(1). 1–5. 132 indexed citations

18.

Jackson, Lisa A., Onchee Yu, Jennifer C. Nelson, et al.. (2009). Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: A Vaccine Safety Datalink study. Vaccine. 27(36). 4912–4916. 24 indexed citations

19.

Haber, Penina, Mansi Patel, Héctor S. Izurieta, et al.. (2008). Monitorización de la invaginación tras la autorización de la vacuna RotaTeq en Estados Unidos, 1-2-2006/25-9-2007. PEDIATRICS. 65(6). 307–313. 1 indexed citations

20.

Masciotra, Silvina, Waldo Belloso, Liliana Clara, et al.. (2000). Sequence Note: Evidence of a High Frequency of HIV-1 Subtype F Infections in a Heterosexual Population in Buenos Aires, Argentina. AIDS Research and Human Retroviruses. 16(10). 1007–1014. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact